GovAI report makes nine recommendations for how AI providers assess and report biological risks under the EU AI Act
GovAI · Research report
Read the source (opens in a new tab)- What happened
- GovAI published a technical report by Bhuvana Sudarshan, Zaheed Kara, Matthew van der Merwe, John Halstead and others on October 19, 2026, on managing biological risks from general-purpose AI models under the EU AI Act.
- Key points
- It says current requirements "grant providers considerable discretion over how biological risks are evaluated, documented, and communicated to the EU AI Office."
- It finds biological risk evaluations hard to compare across providers, focused on standard deployment over contexts such as trusted access programs, and offering "limited visibility" into post-deployment monitoring.
- Its priorities include evaluating trusted access deployments, incident reporting for biological risk, mapping capability thresholds to named responses, and reporting biological uplift in a standardized format.
- The authors say some recommendations "depend on further action by the Office, such as new guidance or a revised Code."
- Evidence
- Policy research report from an AI governance research group, developed with experts in AI safety, governance and biosecurity. It makes recommendations and has no regulatory force.